(Q39635163)

English

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.

scientific article published on 16 June 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

31

object named as

Lisa Pleyer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1

object named as

Richard Greil

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Petra Obrtlíková

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Tomáš Kozák

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Michael Steurer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Johannes Andel

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Sonja Burgstaller

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Eva Mikušková

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Thomas Nösslinger

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Tomáš Papajík

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Miriam Ladická

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Michael Girschikofsky

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Mikuláš Hrubiško

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Ulrich Jäger

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Michael Fridrik

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Martin Pecherstorfer

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Eva Králiková

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Cristina Burcoveanu

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Emil Spasov

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Andreas Petzer

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Georgi Mihaylov

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Julian Raynov

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Horst Oexle

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

August Zabernigg

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Emília Flochová

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Stanislav Palášthy

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Olga Stehlíková

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Michael Doubek

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Petra Altenhofer

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Thomas Melchardt

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Anton Klingler

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Jiří Mayer

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

16 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

The Lancet. Haematology.

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

e317-29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic lymphocytic leukemia: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies?

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

From pathogenesis to treatment of chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab in the treatment of non-Hodgkin's lymphoma--a critical evaluation of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance in CLL.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular and cellular mechanisms of CLL: novel therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The immunodeficiency of chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2816%2930045-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2352-3026(16)30045-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27374465%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39635163&oldid=2105567314"